Despite advances in cancer treatment, breast cancer remains one of the main life
threatening diseases in women. Most anti-breast cancer drugs cause severe health …

Although tamoxifen (TAM) is used for the front‐line treatment and prevention of estrogen
receptor‐positive (ER+) breast tumors, nearly 40% of estrogen‐dependent breast tumors do …

Although Tamoxifen (TAM) is one of the most widely used drugs in managing breast cancer,
many women still relapse after long‐term therapy. Caffeic acid phenethyl ester (CAPE) is a …

Berberine, an isoquinoline alkaloid, has been previously demonstrated to possess anti‑
breast cancer properties. Tamoxifen is widely used in the prevention and treatment of …

Breast cancer is the most diagnosed diseases and the second-leading cause of death in
females, among which the estrogen receptor positive (ER+) patients are more common of all …

Cancer is a disease that affects and kills millions of people worldwide. Breast cancer,
especially, has a high incidence and mortality, and is challenging to treat. Due to its high …

While the survival rate has increased due to treatments for breast cancer, the quality of life
has decreased because of the side effects of chemotherapy. Various toxins are being …

Endocrine sensitivity, assessed by the expression of estrogen receptor (ER), has long been
the predict factor to guide therapeutic decisions. Tamoxifen has been the most successful …

Background Breast cancer intimidates the contemporary medical advances, attempting to
revolutionize cancer therapeutics. While patients suffering an advanced breast cancer are …

Introduction: Tamoxifen (TAM) is the most commonly used hormone therapeutic drug for the
treatment of estrogen receptor-positive (ER+) breast cancer. 30%–70% of clinical breast …